Skip to main content
David Kwiatkowski, MD, Oncology, Boston, MA

David Joseph Kwiatkowski MD


Professor of Medicine, Brigham and Women's Hospital

Join to View Full Profile
  • 20 Shattuck St.Boston, MA 02115

  • Phone+1 857-307-0781

  • Fax+1 617-394-2769

Dr. Kwiatkowski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1979 - 1984
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1979
  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1986 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1995
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Tuberin Regulates Prostaglandin Receptor–Mediated Viability, via Rheb, in mTORC1-Hyperactive Cells  
    Darcy A Krueger, David N Franz, David J Kwiatkowski, Kantha Medepalli, Brian J Siroky, Jamie K Capal, Clinical Cancer Research
  • Institutional Implementation of Clinical Tumor Profiling on an Unselected Cancer Population  
    Khanh Do, Lauren L Ritterhouse, William C Hahn, Geoffrey I Shapiro, Barrett J Rollins, Neal I Lindeman, Alanna Church, Geoffrey R Oxnard, Bruce E Johnson, Frank C Kuo,..., The Journal of Clinical Investigation

Lectures

  • Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Interim analysis and biomarker data from a multicenter study (LCMC3). 
    2019 ASCO Annual Meeting - 6/1/2019

Authored Content

  • Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase InhibitorsJanuary 2018

Press Mentions

  • Study Identifies Genomic Predictors of Outcomes in High-Risk Bladder Cancer
    Study Identifies Genomic Predictors of Outcomes in High-Risk Bladder CancerSeptember 23rd, 2020
  • Effect of Erlotinib plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical Trial
    Effect of Erlotinib plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical TrialAugust 8th, 2019

Grant Support

  • Molecular Pathogenesis of the Hamartoma SyndromesBRIGHAM AND WOMEN'S HOSPITAL2007–2028
  • Molecular Pathogenesis of the Hamartoma SyndromesBRIGHAM AND WOMEN'S HOSPITAL2007–2028
  • Molecular Pathogenesis of the Hamartoma SyndromesBRIGHAM AND WOMEN'S HOSPITAL2007–2028
  • Genetics of LAMBRIGHAM AND WOMEN'S HOSPITAL2020–2025
  • Mouse Brain Models Of Tuberous SclerosisNational Institute Of Neurological Disorders And Stroke2008–2012
  • Tuberous Sclerosis: Mutations And Murine ModelsNational Institute Of Neurological Disorders And Stroke2007–2012
  • The Lymphangioleiomyomatosis (Lam)Genome AtlasNational Heart, Lung, And Blood Institute2009–2010
  • Preclinical Studies Of Rapamycin For TSC Brain DiseaseNational Institute Of Neurological Disorders And Stroke2004–2006
  • Tuberous Sclerosis: Mutations And Murine ModelsNational Institute Of Neurological Disorders And Stroke2002–2006
  • Genotyping Center For Innate Immunity PGANational Heart, Lung, And Blood Institute2000–2004
  • Gelsolin: Roles In Apoptosis And Tumor DevelopmentNational Heart, Lung, And Blood Institute2001–2003
  • Murine Models Of Tsc1: Mechanisms And TherapiesNational Institute Of Neurological Disorders And Stroke2001–2002
  • Murine Models Of TSC 1: Mechanisms And TherapiesNational Institute Of Neurological Disorders And Stroke2001
  • Tuberous Sclerosis--Mutations And Murine ModelsNational Institute Of Neurological Disorders And Stroke1998–2001
  • Gelsolin--Roles In Apoptosis And Tumor DevelopmentNational Heart, Lung, And Blood Institute2000
  • Actin Regulatory Proteins In Arterial DysfunctionNational Heart, Lung, And Blood Institute1997–1998
  • Gelsolin'S Role In Motility And Host DefenseNational Heart, Lung, And Blood Institute1996–1998
  • Tuberous Sclerosis Gene On 9q34National Institute Of Neurological Disorders And Stroke1994–1997
  • Gelsonlin'S Role In Motility And Host DefenseNational Heart, Lung, And Blood Institute1995
  • International Workshop On Human Chromosome 9National Human Genome Research Institute1994
  • Human Chromosome 9National Human Genome Research Institute1993
  • MAP Of Human Chromosome 9National Human Genome Research Institute1991–1993
  • Molecular Biology Of GelsolinNational Heart, Lung, And Blood Institute1985–1989

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: